Advertisement

CYP1A1 and CYP1B1 Polymorphisms and Their Association with Estradiol and Estrogen Metabolites in Women Who Are Premenopausal and Perimenopausal

      Abstract

      The purpose of this study was to relate measured concentrations of estradiol (E2) and the urinary estrogen metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16α-OHE1) to single nucleotide polymorphisms (SNPs) from CYP1A1 and CYP1B1, the primary genes involved in estrogen catabolism. We investigated the association of 4 CYP1A1 SNPs (CYP1A1 rs4646903, CYP1A1 rs1531163, CYP1A1 rs2606345, and CYP1A1 rs1048943) and 2 CYP1B1 SNPs (CYP1B1 rs162555 and CYP1B1 rs1056836) to circulating serum E2 concentrations and the urinary estrogen metabolites 2-OHE1 and 16α-OHE1. The associations were evaluated in 1,340 participants of 4 racial/ethnic groups from the Study of Women’s Health Across the Nation (SWAN) who were premenopausal and perimenopausal. There was substantial variation in the allele frequencies of the SNPs for African American and Caucasian women. There was, however, remarkable comparability between Chinese and Japanese women; their CYP1A1 and CYP1B1 allele frequencies differed by only ≤11%. There was significant variation in E2 concentrations by genotype within racial/ethnic group for CYP1A1 rs2606345. In particular, Japanese women with the CC genotype had lower E2 concentrations than did Japanese women with the AC genotype. Chinese women with the CC genotype had higher 2-OHE1 concentrations than did Chinese women with the AC genotype. Further, African American women with the CC genotype had higher 16α-OHE1 concentrations than did those with other genotypes. CYP1A1 rs2606345 may play an important role in estrogen metabolism in women who are premenopausal and perimenopausal.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aktas D.
        • Guney I.
        • Alikasifoglu M.
        • Yüce K.
        • Tuncbilek E.
        • Ayhan A.
        CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
        Gynecol Oncol. 2002; 86: 124-128
        • De Vivo I.
        • Hankinson S.E.
        • Li L.
        • Colditz G.A.
        • Hunter D.J.
        Association of CYP1B1 polymorphisms and breast cancer risk.
        Cancer Epidemiol Biomarkers Prev. 2002; 11: 489-492
        • Napoli N.
        • Villareal D.T.
        • Mumm S.
        • et al.
        Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density.
        J Bone Miner Res. 2005; 20: 232-239
        • Mueck A.O.
        • Seeger H.
        • Lippert T.H.
        Estradiol metabolism and malignant disease.
        Maturitas. 2002; 43: 1-10
        • Zhu B.T.
        • Conney A.H.
        Functional role of estrogen metabolism in target cells: review and perspectives.
        Carcinogenesis. 1998; 19: 1-27
        • Martucci C.P.
        • Fishman J.
        P450 enzymes of estrogen metabolism.
        Pharmacol Ther. 1993; 57: 237-257
        • Schneider J.
        • Huh M.M.
        • Bradlow H.L.
        • Fishman J.
        Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.
        J Biol Chem. 1984; 259: 4840-4845
        • Kabat G.C.
        • Chang C.J.
        • Sparano J.A.
        • et al.
        Urinary estrogen metabolites and breast cancer: a case-control study.
        Cancer Epidemiol Biomarkers Prev. 1997; 6: 505-509
      1. GeneCard for protein-coding CYP1A1 GC15M072798. Web site of the Weizmann Institute of Science. Available at: http://www.genecards.org/cgi-bin/carddisp?CYP1A1. Accessed October 4, 2005.

      2. National Center for Biotechnology Information (NCBI) Entrez SNP. Search for CYP1A1 and CYP1B1. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=snp. Accessed September 23, 2005.

        • Corchero J.
        • Pimprale S.
        • Kimura S.
        • Gonzalez F.J.
        Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.
        Pharmacogenetics. 2001; 11: 1-6
      3. GeneCard for protein-coding CYP1B1 GC02M038206. Web site of the Weizmann Institute of Science. Available at: http://www.genecards.org/cgi-bin/carddisp?CYP1B1. Accessed October 4, 2005.

        • Kress S.
        • Greenlee W.F.
        Cell-specific regulation of human CYP1A1 and CYP1B1 genes.
        Cancer Res. 1997; 57: 1264-1269
        • Angus W.G.R.
        • Larsen M.C.
        • Jefcoate C.R.
        Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
        Carcinogenesis. 1999; 20: 947-955
      4. Single Nucleotide Polymorphism database: dbSNP search page. National Center for Biotechnology Information Web site. Available at: http://www.ncbi.nlm.nih.gov/SNP/. Accessed September 23, 2005.

        • Sowers M.F.
        • Crawford S.
        • Sternfeld B.
        • et al.
        Design, survey sampling and recruitment methods of SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition.
        in: Lobo R.A. Kelsey J. Marcus R. Menopause: Biology and Pathobiology. Academic Press, San Diego, CA2000: 175-188
        • Kardia S.R.
        • Chu J.
        • Sowers M.F.R.
        Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women’s Health Across the Nation (SWAN).
        Am J Med. 2006; 119: S3-S15
        • Santoro N.
        • Crawford S.L.
        • Allsworth J.E.
        • et al.
        Assessing menstrual cycles with urinary hormone assays.
        Am J Physiol Endocrinol Metab. 2003; 284: E521-E530
        • Klug T.L.
        • Bradlow H.L.
        • Sepkovic D.W.
        Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine.
        Steroids. 1994; 59: 648-655
        • Ferris B.G.
        Epidemiology Standardization Project (American Thoracic Society).
        Am Rev Respir Dis. 1978; 188: 1-120
        • Miyoshi Y.
        • Noguchi S.
        Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
        Biomed Pharmacother. 2003; 57: 471-481
        • Inoue K.
        • Asao T.
        • Shimada T.
        Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
        Xenobiotica. 2000; 30: 285-295
        • Yoshimura K.
        • Hanaoka T.
        • Ohnami S.
        • et al.
        Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples.
        J Hum Genet. 2003; 48: 654-658
        • Tworoger S.S.
        • Chubak J.
        • Aiello E.J.
        • et al.
        Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
        Cancer Epidemiol Biomarkers Prev. 2004; 13: 94-101